Wart Remover

Description

Liquid Wart Remover is a topical formulation designed for the removal of warts. It is presented in a liquid dosage form, allowing for direct application to affected areas. The product is specifically formulated to target and eliminate common warts through a precise mechanism of action.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, cauliflower-like surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and an interruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly prior to treatment. For optimal results, the wart may be soaked in warm water for approximately 5 minutes, followed by thorough drying of the area.

Using the provided applicator, one drop of the medication should be applied at a time to ensure sufficient coverage of each wart. After application, the treated area should be allowed to dry completely.

To conceal the wart, self-adhesive cushioning pads may be utilized. The application procedure may be repeated once or twice daily as needed, continuing until the wart is removed, with a maximum treatment duration of up to 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

Patients with diabetes should not use this product due to potential complications associated with glycemic control.

Individuals with poor blood circulation are advised against use, as it may exacerbate their condition.

Application is contraindicated on irritated skin or any area that is infected or reddened, as this may lead to further irritation or infection.

The product should not be applied to moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes, due to the risk of adverse reactions or complications.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame to prevent any risk of ignition.

It is essential to keep this product out of the reach of children to avoid accidental ingestion or misuse. In the event of swallowing the product, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

Users are advised to discontinue use and consult a healthcare professional if discomfort persists. Monitoring for any adverse reactions is recommended to ensure safe usage.

Side Effects

Patients should be aware that the product is for external use only and is flammable; it should be kept away from fire or flame to prevent any potential hazards.

In clinical practice, if patients experience discomfort that persists, they are advised to stop using the product and consult a healthcare professional for further evaluation and guidance.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Wart Remover (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The safety of this product during pregnancy has not been established. Use of this product is not recommended during pregnancy due to potential risks to the fetus. Healthcare professionals should consider alternative treatments for pregnant patients and counsel women of childbearing potential regarding the potential risks associated with the use of this product during pregnancy.

Lactation

Nursing mothers should be aware of the potential for excretion of salicylic acid in breast milk. Caution is advised when using this product while breastfeeding due to the potential risk to the infant.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the text. Therefore, healthcare professionals should exercise caution and consider individual patient factors when prescribing to this population. Regular assessment of renal function may be warranted to ensure safe and effective use of the medication in patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If the substance involved is known, specific antidotes or treatments may be indicated, and healthcare professionals should refer to established guidelines for the management of overdose related to that particular substance.

In all cases, contacting a poison control center or a medical toxicologist for guidance is recommended to ensure appropriate management and intervention.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control Center immediately. This guidance is crucial for ensuring patient safety and minimizing potential risks associated with accidental exposure.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which are essential for identification and inventory management. It is crucial to store the product within the temperature range of 20° to 25°C (68° to 77°F) to maintain its efficacy and stability. Additionally, the container must be kept tightly closed to prevent contamination and ensure the integrity of the product. Proper adherence to these storage conditions is vital for optimal performance.

Additional Clinical Information

The medication is administered topically, with the recommended procedure to be repeated once or twice daily as needed until the wart is removed, for a maximum duration of 12 weeks. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)